Yao Naxin
Directeur/Bestuurslid bij Hangzhou Qihan Biotech Co., Ltd.
Profiel
Yao Naxin is the founder of Kadang.com, which was founded in 2006.
Currently, Mr. Naxin is an Independent Director at Hangzhou Qihan Biotech Co., Ltd.
since 2023.
Previously, Mr. Naxin worked as a Director at KASB Corp.
Mr. Naxin's education includes an undergraduate degree from Peking University, a graduate degree from the University of California, Berkeley, and a graduate degree from Stanford Graduate School of Business.
Actieve functies van Yao Naxin
Bedrijven | Functie | Begin |
---|---|---|
Hangzhou Qihan Biotech Co., Ltd.
Hangzhou Qihan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then. | Directeur/Bestuurslid | 28-07-2023 |
Eerdere bekende functies van Yao Naxin
Bedrijven | Functie | Einde |
---|---|---|
Kadang.com
Kadang.com Internet Software/ServicesTechnology Services Kadang.com is engaged in the provision of online retail shopping services. Its offers customized services and personalized gifts such as fashion jewelry, fine jewelry, T-shirts, mugs, crystal, prints, home accessories, and other various items. The company was founded by Fang Qin and co-founded by Yao Naxin in June 2006 and is headquartered in Hangzhou, China. | Oprichter | - |
KASB Corp.
KASB Corp. Finance/Rental/LeasingFinance KASB Corp. is engaged in the business of leasing. It provides full payout financial leases against plant and machinery, office equipment and vehicles. The company's other services include consumer lease finance and micro leasing. KASB was founded on April 11, 1996 and is headquartered in Karachi, Pakistan. | Directeur/Bestuurslid | - |
Opleiding van Yao Naxin
Peking University | Undergraduate Degree |
University of California, Berkeley | Graduate Degree |
Stanford Graduate School of Business | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
KASB Corp.
KASB Corp. Finance/Rental/LeasingFinance KASB Corp. is engaged in the business of leasing. It provides full payout financial leases against plant and machinery, office equipment and vehicles. The company's other services include consumer lease finance and micro leasing. KASB was founded on April 11, 1996 and is headquartered in Karachi, Pakistan. | Finance |
Kadang.com
Kadang.com Internet Software/ServicesTechnology Services Kadang.com is engaged in the provision of online retail shopping services. Its offers customized services and personalized gifts such as fashion jewelry, fine jewelry, T-shirts, mugs, crystal, prints, home accessories, and other various items. The company was founded by Fang Qin and co-founded by Yao Naxin in June 2006 and is headquartered in Hangzhou, China. | Technology Services |
Hangzhou Qihan Biotech Co., Ltd.
Hangzhou Qihan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then. | Health Services |